Showing results (311-320 of 385) with videos related to

Sort By:
Pageof 39
Vaccine|August 7, 2004
A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccineKevin A Ault, Anna R Giuliano, Robert P Edwards, et al.
The American Journal of Gastroenterology|April 27, 2018
Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trialsPhilippe J Zamor, John Vierling, Reem Ghalib, et al.
Science (New York, N.Y.)|October 16, 2025
Head-direction cells as a neural compass in bats navigating outdoors on a remote oceanic islandShaked Palgi, Saikat Ray, Shir R Maimon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2018
Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysisTarik Asselah, Hendrik Reesink, Jan Gerstoft, et al.
Journal of Oral Rehabilitation|November 1, 2018
The effect of orthodontic separator and short-term fixed orthodontic appliance on inflammatory mediators and somatosensory functionFernanda A Sampaio, Claudine R A Sampaio, Carolina O Cunha, et al.
The Pediatric Infectious Disease Journal|December 3, 2009
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccineStan L Block, Darron R Brown, Archana Chatterjee, et al.
Journal of Clinical Medicine|March 28, 2024
Clinical and Radiological Characteristics of Non-Obese Female Patients with Idiopathic Intracranial HypertensionAnat Horev, Gal Ben-Arie, Yair Zlotnik, et al.
Pediatrics|November 3, 2006
Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult womenStan L Block, Terry Nolan, Carlos Sattler, et al.
The Pediatric Infectious Disease Journal|May 9, 2007
Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trialKeith S Reisinger, Stan L Block, Eduardo Lazcano-Ponce, et al.
International Journal of Cancer|November 15, 2007
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American womenGonzalo Perez, Eduardo Lazcano-Ponce, Mauricio Hernandez-Avila, et al.
Pageof 39